Ajanta Pharma shares gain 2.16%; among top gainers on Nifty Midcap 150
At 12:35 pm on Monday, shares of Ajanta Pharma rose 2.16% to Rs 2,683.30, making it one of the top gainers on the Nifty Midcap 150 index. This increase reflects positive investor sentiment towards the stock.
Consolidated Quarterly Financial Performance:
The following table summarizes Ajanta Pharma's consolidated quarterly financial performance:
HeadingMar 2024Jun 2024Sep 2024Dec 2024
Mar 2025
RevenueRs 1,054.08 CroreRs 1,144.92 CroreRs 1,186.64 CroreRs 1,146.13 Crore
Rs 1,170.41 CroreNet ProfitRs 202.72 CroreRs 245.77 CroreRs 216.48 CroreRs 232.88 Crore
Rs 225.26 CroreEPS16.1019.5417.2718.60
18.00
Analyzing the quarterly data, Ajanta Pharma's revenue increased by 10.9% from Rs 1,054.08 Crore in March 2024 to Rs 1,170.41 Crore in March 2025. However, there was a slight decrease in net profit, which fell by 6.0% from Rs 245.77 Crore in June 2024 to Rs 225.26 Crore in March 2025. The earnings per share (EPS) also experienced fluctuations, settling at Rs 18.00 for the quarter ending March 2025.
Consolidated Yearly Financial Performance:
The following table presents Ajanta Pharma's consolidated yearly financial performance:
Heading2021202220232024
2025
RevenueRs 2,889.69 CroreRs 3,340.99 CroreRs 3,742.64 CroreRs 4,208.71 Crore
Rs 4,648.10 CroreNet ProfitRs 653.87 CroreRs 712.68 CroreRs 587.98 CroreRs 816.17 Crore
Rs 920.39 CroreEPS75.0982.4545.8964.82
73.56BVPS344.52380.24268.14282.34
302.38ROE21.8221.8317.3522.87
24.28Debt to Equity0.000.000.000.00
0.00
From the yearly data, the company's revenue saw a substantial increase of 60.8% from Rs 2,889.69 Crore in 2021 to Rs 4,648.10 Crore in 2025. Net profit also rose significantly by 40.7% from Rs 653.87 Crore in 2021 to Rs 920.39 Crore in 2025. The earnings per share (EPS) showed a decrease from Rs 82.45 in 2022 to Rs 73.56 in 2025. Additionally, the return on equity (ROE) improved from 21.82% in 2021 to 24.28% in 2025, while the company maintained a consistent debt-to-equity ratio of 0.00 throughout the period.
Key Financial Ratios:
RatioMar 2021Mar 2022Mar 2023Mar 2024
Mar 2025
Basic EPS (Rs.)75.0982.4545.8964.82
73.56Diluted Eps (Rs.)75.0982.4545.8964.77
73.53Book Value /Share (Rs.)344.52380.24268.14282.34
302.38Dividend/Share (Rs.)9.509.507.0051.00
28.00Face Value2222
2
The dividend per share decreased from Rs 51.00 in March 2024 to Rs 28.00 in March 2025. The book value per share also increased from Rs 282.34 to Rs 302.38 during the same time.
Corporate Actions:
Ajanta Pharma has a history of corporate actions, including dividends and bonus issues. The company announced an interim dividend of Rs 28 per share on October 25, 2024, with an effective date of November 6, 2024. Previously, on May 10, 2022, Ajanta Pharma announced a bonus issue with a ratio of 1:2, the ex-bonus date for which was June 22, 2022.The stock's current price is Rs 2,683.30, with a 2.16% increase, making it a notable gainer in today's trading session.